Summary
Updated Aug 30, 2026
Jeremy M. Levin is Executive Chairman of Ovid Therapeutics Inc. (OVID). 2 SEC Form 4 filings on record, most recently on 26 March 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Jeremy M. Levin has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeremy M. Levin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Margaret A. Alexander - $17K of OVID open-market activity in the last 12 months
- Jeffrey A. Rona - $12K of OVID open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jeremy M. Levin?
Jeremy M. Levin is a corporate insider, tracked as Executive Chairman of Ovid Therapeutics Inc. (OVID). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jeremy M. Levin last file a Form 4?
The most recent primary Form 4 on record is dated 26 March 2026, one of 2 filings going back to 2026.
Where can I see all of Jeremy M. Levin's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jeremy M. Levin and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
